Journal article icon

Journal article : Review

The Prognostic Value of Pre-Procedural and Post-Procedural Inflammatory–Oxidative Stress Biomarkers in Acute Coronary Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

Abstract:
Acute coronary syndrome patients undergoing percutaneous coronary intervention remain at high risk for major adverse cardiovascular events (MACE: cardiovascular mortality, non-fatal myocardial infarction, and stroke). Inflammatory–oxidative stress biomarkers are potential prognostic tools; however, the influence of sampling timing—pre-procedural versus post-procedural—remains unclear. This meta-analysis evaluated six biomarkers: sST2, GDF-15, OPG, sLOX-1, H-FABP, and Galectin-3. Pooled Hazard Ratios (HRs) for time-to-event outcomes and Standardized Mean Differences (SMDs) between event and non-event groups were synthesized using random-effects models involving 40 studies (18,933 patients). Elevated pre-procedural levels of sST2 (HR = 3.32, p < 0.0001), GDF-15 (HR = 3.00, p < 0.0001), sLOX-1 (HR = 2.61, p = 0.0023), and OPG (HR = 1.79, p = 0.0206) significantly predicted MACE. Notably, pre-PCI sST2 strongly predicted heart failure hospitalization (HR = 6.30, p < 0.0001). Additionally, pre-PCI H-FABP demonstrated a moderate significant effect on adverse outcomes (SMD = 0.67, p < 0.0001). While pre-PCI Galectin-3 was not significant, its post-procedural levels showed a large significant effect (SMD = 1.15, p < 0.0001). In conclusion, inflammatory and oxidative stress biomarkers, particularly sST2 and GDF-15, demonstrate consistent associations with adverse outcomes in ACS patients undergoing PCI, offering more reliable baseline risk stratification than post-procedural measurements.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.3390/ijms27083389

Authors

More by this author
Role:
Author
ORCID:
0009-0005-3210-0641
More by this author
Role:
Author
ORCID:
0000-0001-5180-957X
More by this author
Role:
Author
ORCID:
0000-0002-5603-9487
More by this author
Role:
Author
ORCID:
0009-0008-0317-7377


More from this funder
Funder identifier:
https://ror.org/05p2xef58
Grant:
Contract No. 4300/B3/DT.03.08/2025


Publisher:
MDPI
Journal:
International Journal of Molecular Sciences More from this journal
Volume:
27
Issue:
8
Pages:
3389
Article number:
3389
Publication date:
2026-04-09
Acceptance date:
2026-04-07
DOI:
EISSN:
1422-0067
ISSN:
1661-6596


Language:
English
Keywords:
Subtype:
Review
Source identifiers:
4040715
Deposit date:
2026-05-13
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP